Surgical Wound Infection clinical trials at UCSF
1 research study open to eligible people
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
open to eligible people ages 18 years and up
The DECREASE SSI Trial (Decolonization to Reduce After-Surgery Events of Surgical Site Infection) is a two-arm multi-center individual placebo-controlled randomized (2,700 participants randomized 1:1) clinical trial to reduce post-discharge surgical site infection following open colon or small bowel surgery by comparing chlorhexidine bathing plus nasal mupirocin in the 30 days following discharge to soap without antiseptic properties (placebo) and placebo nasal ointment. This trial seeks to enhance the care of the 675,000 patients annually who undergo colon and small bowel surgery by finding simple and efficacious interventions to reduce SSI.
San Francisco, California and other locations
Our lead scientists for Surgical Wound Infection research studies include Deborah Yokoe, MD, MPH.